Alain Merieux Net Worth

Alain Merieux is the chairman of Institut Merieux, a medicine and public health conglomerate founded by his grandfather, Marcel Merieux, in 1897. Alain founded BioMerieux, one of the firm's publicly traded arms, which specializes in diagnostic tests for infectious diseases. Transgene, another publicly-traded subsidiary, develops vaccines to combat infectious diseases. Alain's sons, Rodolphe, Christophe, and Alexandre, have all been involved in the family business, with Alexandre taking over as CEO of BioMerieux in 2014. In 2015, Alain was made Grand Officer in the French Legion of Honour for his service in the global health industry.
Alain Merieux is a member of Health care

Age, Biography and Wiki

Birth Place	Lyon, France, France
Residence	Lyon, France
Occupation	Chairman, Institut Mérieux
Children	3

💰 Net worth: $6.3 Billion (2024)

Alain Merieux' net worth is estimated to be $6.3 billion in 2024. Alain Merieux is a prominent figure in the field of healthcare in France. As the head of the multinational bio-pharmaceutical company, Merieux Alliance, he has played a pivotal role in advancing medical innovation, diagnostics, and vaccines. With a focus on improving global public health, his contributions have been recognized worldwide. Alain Merieux' net worth reflects not only his business acumen but also his dedication to revolutionizing healthcare solutions and making a significant impact on the well-being of individuals and communities.

2009 $2.4 Billion

2010 $4 Billion

2011 $4.3 Billion

2012 $3.7 Billion

2013 $3.1 Billion

2014 $3.8 Billion

2015 $3.5 Billion

2016 $3.3 Billion

2017 $4 Billion

2018 $3.15 Billion